Literature DB >> 15715550

Endophthalmitis following cataract surgery in Sweden: national prospective survey 1999-2001.

Gisela Wejde1, Per Montan, Mats Lundström, Ulf Stenevi, William Thorburn.   

Abstract

PURPOSE: To investigate the epidemiology of postoperative endophthalmitis (POE) following cataract surgery in Sweden during a 3-year period, using the framework of the Swedish National Cataract Register.
METHODS: Clinically presumed cases of POE were reported in a prospective survey involving all Swedish ophthalmic surgical units except one. Data on results of the intraocular culture and visual outcome after infection, as well as patient age and gender and various elements of the surgical procedure, were collected.
RESULTS: The nationwide incidence of POE was 0.0595%, representing 112 cases in 188 151 cataract operations. Gram-positive bacteria were the predominant aetiology, with an 84.6% share of culture-positive cases. A significantly decreased risk for POE was found for patients who had received prophylactic intracameral antibiotics (mainly cefuroxime) in comparison with those who had been treated with topical antibiotics only.
CONCLUSIONS: The prevalence of POE after cataract surgery in Sweden is at the lower end of the spectrum of incidence currently reported in the developed world. The administration of intracameral antibiotics may have contributed to these results.

Entities:  

Mesh:

Year:  2005        PMID: 15715550     DOI: 10.1111/j.1600-0420.2005.00377.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  28 in total

1.  Postcataract surgery endophthalmitis in the United States: analysis of the complete 2003 to 2004 Medicare database of cataract surgeries.

Authors:  Lisa Keay; Emily W Gower; Sandra D Cassard; James M Tielsch; Oliver D Schein
Journal:  Ophthalmology       Date:  2012-01-31       Impact factor: 12.079

2.  Comparison of the influence of intracameral gentamicin, gatifloxacin, and moxifloxacin on the corneal endothelium in a rabbit model.

Authors:  Shinichiro Kobayakawa; Yoshimune Hiratsuka; Yasuo Watabe; Akira Murakami; Tetsuo Tochikubo
Journal:  Jpn J Ophthalmol       Date:  2010-11-05       Impact factor: 2.447

Review 3.  Prophylaxis of postoperative endophthalmitis following cataract surgery: current status and future directions.

Authors:  Robert E Fintelmann; Ayman Naseri
Journal:  Drugs       Date:  2010-07-30       Impact factor: 9.546

4.  Incidence of endophthalmitis and the perioperative practices of cataract surgery in Japan: Japanese Prospective Multicenter Study for Postoperative Endophthalmitis after Cataract Surgery.

Authors:  Tomoyuki Inoue; Toshihiko Uno; Norio Usui; Shinichiro Kobayakawa; Kiyoshi Ichihara; Yuichi Ohashi
Journal:  Jpn J Ophthalmol       Date:  2017-11-01       Impact factor: 2.447

5.  Pharmacokinetics of vancomycin following intracameral bolus injection in patients undergoing phacoemulsification cataract surgery.

Authors:  Conor C Murphy; Steven Nicholson; Say Aun Quah; Mark Batterbury; Timothy Neal; Stephen B Kaye
Journal:  Br J Ophthalmol       Date:  2007-03-27       Impact factor: 4.638

Review 6.  Bacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host-microbe interactions in intraocular infection.

Authors:  Ama Sadaka; Marlene L Durand; Michael S Gilmore
Journal:  Prog Retin Eye Res       Date:  2012-04-11       Impact factor: 21.198

7.  Incidence of endophthalmitis after phacoemulsification cataract surgery: a Meta-analysis.

Authors:  Si-Lu Shi; Xiao-Ning Yu; Yi-Lei Cui; Si-Fan Zheng; Xing-Chao Shentu
Journal:  Int J Ophthalmol       Date:  2022-02-18       Impact factor: 1.779

Review 8.  Intracameral cefuroxime: prophylaxis of postoperative endophthalmitis after cataract surgery.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

9.  Endophthalmitis: A review of recent trends.

Authors:  Janice R Safneck
Journal:  Saudi J Ophthalmol       Date:  2012-03-03

10.  Are cefuroxime and vancomycin really safe on the corneal endothelial cells?

Authors:  Tök Y Ozlem; Demir M Necati; Yilmaz M Fatma; Yilmaz Gülsen; Nurözler B Ayşe; Ornek Firdevs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.